SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001193805-03-000083
Filing Date
2003-02-13
Accepted
2003-02-13 12:37:53
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13G e300060_sc13ga-biosante.txt SC 13G/A 9414
  Complete submission text file 0001193805-03-000083.txt   11387
Mailing Address 175 OLDE HALF DAY ROAD SUITE 123 LINCOLNSHIRE IL 60069
Business Address 175 OLDE HALF DAY ROAD SUITE 123 LINCOLNSHIRE IL 60069 8477932458
BIOSANTE PHARMACEUTICALS INC (Subject) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: WY | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-60689 | Film No.: 03557640
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O FIRST NEW YORK SECURITIES, LLC 850 THIRD AVENUE, 8TH FLOOR NEW YORK NY 10022
Business Address
EDELMAN JOSEPH (Filed by) CIK: 0001164426 (see all company filings)